Old Web
English
Sign In
Acemap
>
authorDetail
>
Linda A. Meyerson
Linda A. Meyerson
Medicine
Immunology
Thymopentin
Immunopathology
Asymptomatic
4
Papers
162
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The prognostic significance of serum viral load, codon 215 reverse transcriptase mutation and CD4+ T cells on progression of HIV disease in a double-blind study of thymopentin.
1996
AIDS
Thomas C. Merigan
Robert L. Hirsch
Alan C. Fisher
Linda A. Meyerson
Gideon Goldstein
Mark A. Winters
Show All
Source
Cite
Save
Citations (23)
Safety and efficacy of thymopentin in zidovudine (AZT)-treated asymptomatic HIV-infected subjects with 200-500 CD4 cells/mm3: a double-blind placebo-controlled trial.
1995
Journal of Acquired Immune Deficiency Syndromes
Gideon Goldstein
Marcus A. Conant
Gildon N. Beall
Howard Grossman
Jeffrey E. Galpin
Gary Blick
Leonard H. Calabrese
Robert L. Hirsch
Alan C. Fisher
Patti Stampone
Linda A. Meyerson
Show All
Source
Cite
Save
Citations (5)
Maintenance of CD4+ cells by thymopentin in asymptomatic HIV-infected subjects: results of a double-blind, placebo-controlled study.
1992
AIDS
Marcus A. Conant
Leonard H. Calabrese
Sumner E. Thompson
Bernard J Poiesz
Suraiya Rasheed
Robert L. Hirsch
Linda A. Meyerson
Kremer Ab
Chien-Chun Wang
Gideon Goldstein
Show All
Source
Cite
Save
Citations (19)
Thymopentin therapy reduces the clinical severity of atopic dermatitis
1990
The Journal of Allergy and Clinical Immunology
Donald Y.M. Leung
Robert L. Hirsch
Lynda C. Schneider
Curtis T. Moody
Roberto Takaoka
Shihua H. Li
Linda A. Meyerson
Shiferaw G. Mariam
Gideon Goldstein
Jon M. Hanifin
Show All
Source
Cite
Save
Citations (115)
1